Referring to the postponement of Congress "Diagnostic Histopathology and Molecular Pathology of Gynecological Tumors" due to the recent health emergency, on behalf of Prof. Dei Tos we inform you that the Congress will be postponed to 2021 in virtual mode.
We hope You will be able again to take part to Diagnostic Histopathology and Molecular Pathology of Gynecological Tumors with the new format.
We will inform You as soon as possible about the new scheduled dates.
Sure of your understanding, we thank you for the attention.
The Secretariat and CME Provider
Doc Congress Srl
Angelo Paolo Dei Tos
Professor of Pathology,
Director of Pathology Department of Medicine,
University of Padua School of Medicine, Padova (Italy)
Prof. Matteo Fassan
Associate Professor of Pathology University of Padua School of Medicine, Padova (Italy)
Pathology Department of Medicine, University of Padua School of Medicine, Padova (Italy)
Marisa Rose Nucci
Professor of Pathology Harvard Medical School; Director, Division of Women’s and Perinatal Pathology, Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts USA
Assistant Professor of Pathology at the Stanford University Medical Center Department of Pathology Stanford, California Usa
IDENTIFIED PROFESSIONAL PRACTICE GAPS:
Increasing complexity of gynecological oncologic pathology related to the need of precision medicine
Increasing complexity of gynecological oncologic pathology related to extreme segmentation of tumor entities
Necessity to integrate morphology with new molecular findings
Necessity to provide medical oncologists with reliable prognostic and predictive biomarkers
After successful completion of the educational activities, participants should be able to:
Recognize the diagnostic challenges of major subsets of oncologic gynecological pathology.
Correlate morphology with immunophenotypical and molecular findings.
Interpret morphologic findings in the appropriate clinical context.
Answer the need for more robust prognostic and predictive biomarkers.
Understand future research directions and potentials for changing the clinicopathologic landscape in specific fields of gynecological oncologic pathology.
University of Padua
ERN - EURACAN